XML 37 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FAIR VALUE MEASUREMENTS (Tables)
 3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets Measured on Recurring Basis
As of March 31, 2024 and December 31, 2023, the assets and liabilities measured at fair value on a recurring basis were as set forth in the table below:
 
 
 
(In millions)		March 31, 2024Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Cash equivalents$11.3 $11.3 $— $— 
Share swap transaction0.6 0.6 — — 
Forward currency contracts0.3 — 0.3 — 
Total assets$12.2 $11.9 $0.3 $— 
Liabilities:
Contingent payments related to acquisition$4.5 $— $— $4.5 
Total liabilities$4.5 $— $— $4.5 
December 31, 2023Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)
Assets:
Cash equivalents$10.9 $10.9 $— $— 
Share swap transaction1.1 1.1 — — 
Total assets$12.0 $12.0 $— $— 
Liabilities:
Contingent payments related to acquisition$3.0 $— $— $3.0 
Total liabilities$3.0 $— $— $3.0 
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation The following table provides a roll-forward of the contingent consideration liability, which is included in "Other long-term liabilities" as of December 31, 2023 and "Accrued expenses and other current liabilities" as of March 31, 2024 in the condensed consolidated balance sheets:
Three Months Ended
(In millions)March 31, 2024
Fair value at beginning of period$3.0 
Adjustments to prior year acquisition1.3 
Change in fair value recognized in earnings0.2 
Payments— 
Fair value at end of period$4.5